Otolaryngology-related diseases
Conditions
Interventions
Chitosan Exposure group:None
Erythromycin Ointment Exposure group:None
Recombinant human epidermal growth factor gel Exposure group:None
Recombinant bovine basic fibroblast growth factor gel Exposure group:None
Triamcinolone acetonide Exposure group:None
Chlortetracycline hydrochloride Exposure group:None
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ? Age of 18-65 years old, both sexes; ? The wound was in the following form: type ? and type ? surgical incisions were sutured, and the nasal incision was selected. ? The patient or client agreed to participate in the clinical trial, was willing and able to follow up as required, and could understand and sign the informed consent.
Exclusion criteria
Exclusion criteria: ? Patients with a history of allergy to multiple drugs or recent allergic diseases; ? patients with severe diabetes; ? patients with severe heart, liver, kidney dysfunction or immunodeficiency diseases; ? other conditions judged by the investigator to be unsuitable for enrollment; ? patients who were unable to cooperate with the return visit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding from wounds;Nasal mucosa recovery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Wound pain score;Infection rate; | — |
Countries
China
Contacts
Public ContactZhao Yu
West China Hospital, Sichuan University
Outcome results
None listed